Effect of race and genetics on vitamin D metabolism, bone and vascular health

Nature Reviews Nephrology

Volumn 8, Issue 8, 2012, Pages 459-466

  Freedman, Barry I ^a   Register, Thomas C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; VITAMIN D;

AFRICAN AMERICAN; AGING; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; BONE DENSITY; BONE DISEASE; BONE MINERALIZATION; CALCIUM INTAKE; CALCIUM METABOLISM; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EUROPEAN AMERICAN; GENETIC ASSOCIATION; HUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR; VITAMIN METABOLISM;

ATHEROSCLEROSIS; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CARDIOVASCULAR DISEASES; CHROMOSOME MAPPING; CONTINENTAL POPULATION GROUPS; HUMANS; RENAL INSUFFICIENCY, CHRONIC; VASCULAR CALCIFICATION; VITAMIN D;

EID: 84864340390     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2012.112     Document Type: Review

References (94)

1. Hruska, K. A. et al. Cardiovascular risk in chronic kidney disease (CKD): The CKD-mineral bone disorder (CKD-MBD). Pediatr. Nephrol. 25, 769-778 (2010).
2. Isakova, T. et al. Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J. Am. Soc. Nephrol. 19, 615-623 (2008). (Pubitemid 351355405)
3. Anderson, J., Barnett, E. & Nordin, B. E. The relation between osteoporosis and aortic calcification. Br. J. Radiol. 37, 910-912 (1964).
4. Elkeles, A. A comparative radiological study of calcified atheroma in males and females over 50 years of age. Lancet 273, 714-715 (1957).
5. Browner, W. S. et al. Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke 24, 940-946 (1993). (Pubitemid 23201448)
6. Kiel, D. P. et al. Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham Heart Study. Calcif. Tissue Int. 68, 271-276 (2001). (Pubitemid 32565728)
7. Marcovitz, P. A. et al. Usefulness of bone mineral density to predict significant coronary artery disease. Am. J. Cardiol. 96, 1059-1063 (2005). (Pubitemid 41416595)
8. Ness, J. & Aronow, W. S. Comparison of prevalence of atherosclerotic vascular disease in postmenopausal women with osteoporosis or osteopenia versus without osteoporosis or osteopenia. Am. J. Cardiol. 97, 1427-1428 (2006).
9. Silverman, S. L. et al. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis. J. Am. Geriatr. Soc. 52, 1543-1548 (2004). (Pubitemid 39209605)
10. Tanko, L. B. et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J. Bone Miner. Res. 20, 1912-1920 (2005). (Pubitemid 41532776)
11. Schulz, E. et al. Aortic calcification and the risk of osteoporosis and fractures. J. Clin. Endocrinol. Metab. 89, 4246-4253 (2004). (Pubitemid 39244420)
12. Carr, J. J. et al. Calcified atherosclerotic plaque and bone mineral density in type 2 diabetes: The diabetes heart study. Bone 42, 43-52 (2008). (Pubitemid 350297171)
13. Divers, J. et al. Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes. J. Bone Miner. Res. 26, 1554-1560 (2011).
14. Hofbauer, L. C. et al. Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos. Int. 18, 251-259 (2007). (Pubitemid 46233170)
15. Luo, G. et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386, 78-81 (1997). (Pubitemid 27130923)
16. Speer, M. Y. et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: Evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J. Exp. Med. 196, 1047-1055 (2002). (Pubitemid 35231763)
17. Schafer, C. et al. The serum protein α-2 Heremans Schmid glycoprotein/fetuin A is a systemically acting inhibitor of ectopic calcification. J. Clin. Invest. 112, 357-366 (2003). (Pubitemid 38063764)
18. Kuro o, M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45-51 (1997).
19. Bucay, N. et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12, 1260-1268 (1998). (Pubitemid 28213402)
20. Abedin, M. et al. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). Am. J. Cardiol. 99, 513-518 (2007). (Pubitemid 46215559)
21. Doherty, T. M. et al. Genetic determinants of arterial calcification associated with atherosclerosis. Mayo Clin. Proc. 79, 197-210 (2004). (Pubitemid 38140804)
22. Abedin, M., Tintut, Y. & Demer, L. L. Vascular calcification: Mechanisms and clinical ramifications. Arterioscler. Thromb. Vasc. Biol. 24, 1161-1170 (2004). (Pubitemid 38880003)
23. Demer, L. L. & Tintut, Y. Mineral exploration: Search for the mechanism of vascular calcification and beyond: The 2003 Jeffrey M. Hoeg Award lecture. Arterioscler. Thromb. Vasc. Biol. 23, 1739-1743 (2003). (Pubitemid 37254856)
24. Giachelli, C. M. et al. Regulation of vascular calcification: Roles of phosphate and osteopontin. Circ. Res. 96, 717-722 (2005). (Pubitemid 40559510)
25. Demer, L. L. Vascular calcification and osteoporosis: Inflammatory responses to oxidized lipids. Int. J. Epidemiol. 31, 737-741 (2002). (Pubitemid 34947236)
26. Irving, J. T. & Wuthier, R, E. Histochemistry and biochemistry of calcification with special reference to the role of lipids. Clin. Orthop. Relat. Res. 56, 237-260 (1968).
27. Cotmore, J. M., Nichols, G. Jr & Wuthier, R. E. Phospholipid-calcium phosphate complex: Enhanced calcium migration in the presence of phosphate. Science 172, 1339-1341 (1971).
28. Ennever, J., Vogel, J. J. & Riggan, L. J. Calcification by proteolipid from atherosclerotic aorta. Atherosclerosis 35, 209-213 (1980). (Pubitemid 10212375)
29. Register, T. C., McLean, F. M., Low, M. G. & Wuthier, R. E. Roles of alkaline phosphatase and labile internal mineral in matrix vesicle-mediated calcification. Effect of selective release of membrane-bound alkaline phosphatase and treatment with isosmotic pH 6 buffer. Biol. Chem. 261, 9354-9360 (1986). (Pubitemid 17218217)
30. Shanahan, C. M. et al. Expression of mineralisation-regulating proteins in association with human vascular calcification. Z. Kardiol. 89 (Suppl. 2), 63-68 (2000).
31. Burton, D. G., Matsubara, H. & Ikeda, K: Pathophysiology of vascular calcification: Pivotal role of cellular senescence in vascular smooth muscle cells. Exp. Gerontol. 45, 819-824 (2010).
32. Giachelli, C. M. Vascular calcification mechanisms. J. Am. Soc. Nephrol. 15, 2959-2964 (2004). (Pubitemid 39578826)
33. Ellam, T. J. & Chico, T. J. Phosphate: The new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Atherosclerosis 220, 310-318 (2012).
34. Aloia, J. F. et al. Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am. J. Clin. Nutr. 84, 602-609 (2006). (Pubitemid 44713411)
35. Acheson, L. S. Bone density and the risk of fractures: Should treatment thresholds vary by race? JAMA 293, 2151-2154 (2005). (Pubitemid 40617069)
36. Aloia, J. F. African Americans, 25-hydroxyvitamin D, and osteoporosis: A paradox. Am. J. Clin. Nutr. 88, 545S-550S (2008).
37. Rostand, S. G. Vitamin D, blood pressure, and African Americans: Toward a unifying hypothesis. Clin. J. Am. Soc. Nephrol. 5, 1697-1703 (2010).
38. George, A. et al. Racial differences in bone mineral density in older men. J. Bone Miner. Res. 18, 2238-2244 (2003). (Pubitemid 37463318)
39. Looker, A. C., Melton, L. J. III, Borrud, L. G. & Shepherd, J. A. Lumbar spine bone mineral density in US adults: Demographic patterns and relationship with femur neck skeletal status. Osteoporos. Int. 23, 1351-1360 (2012).
40. Ross, A. C. et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J. Clin. Endocrinol. Metab. 96, 53-58 (2011).
41. Shapses, S. A. & Manson, J. E. Vitamin D and prevention of cardiovascular disease and diabetes: Why the evidence falls short. JAMA 305, 2565-2566 (2011).
42. Ross, A. C., Taylor, C. L. & Yaktine, A. L. (Eds) Dietary reference intakes for calcium and vitamin D (The National Academies Press, Washington DC, 2011).
43. Bell, N. H. et al. Evidence for alteration of the vitamin D endocrine system in blacks. J. Clin. Invest. 76, 470-473 (1985). (Pubitemid 15227507)
44. Bell, N. H. et al. Demonstration of a difference in urinary calcium, not calcium absorption, in black and white adolescents. J. Bone Miner. Res. 8, 1111-1115 (1993). (Pubitemid 23261105)
45. Hustmyer, F. G., DeLuca, H. F. & Peacock, M. ApaI, BsmI, EcoRV and TaqI polymorphisms at the human vitamin D receptor gene locus in Caucasians, blacks and Asians. Hum. Mol. Genet. 2, 487 (1993). (Pubitemid 23107234)
46. Freedman, B. I. et al. Vitamin D, adiposity, and calcified atherosclerotic plaque in African Americans. J. Clin. Endocrinol. Metab. 95, 1076-1083 (2010).
47. Detrano, R. et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med. 358, 1336-1345 (2008). (Pubitemid 351468410)
48. Agarwal, S. et al. Coronary calcium score and prediction of all-cause mortality in diabetes: The diabetes heart study. Diabetes Care 34, 1219-1224 (2011).
49. Aloia, J. F., Talwar, S. A., Pollack, S. & Yeh, J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch. Intern. Med. 165, 1618-1623 (2005). (Pubitemid 41124156)
50. Cauley, J. A. et al. Serum 25 hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: The Womens health initiative (WHI). J. Bone Miner. Res. 26, 2378-2388 (2011).
51. Davies, M. R. & Hruska, K. A. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int. 60, 472-479 (2001). (Pubitemid 32680895)
52. Wolf, M. et al. Impact of activated vitamin D and race on survival among hemodialysis patients. J. Am. Soc. Nephrol. 19, 1379-1388 (2008).
53. Kalantar-Zadeh, K. et al. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J. Bone Miner. Res. 25, 2724-2734 (2010).
54. Dent, C. E., Engelbrecht, H. E. & Godfrey, R. C. Osteoporosis of lumbar vertebrae and calcification of abdominal aorta in women living in Durban. Br. Med. J. 4, 76-79 (1968).
55. Newby, P. K. et al. Race and region are associated with nutrient intakes among black and white men in the United States. J. Nutr. 141, 296-303 (2011).
56. Bersaglieri, T. et al. Genetic signatures of strong recent positive selection at the lactase gene. Am. J. Hum. Genet. 74, 1111-1120 (2004). (Pubitemid 38669310)
57. Swallow, D. M. Genetics of lactase persistence and lactose intolerance. Annu. Rev. Genet. 37, 197-219 (2003). (Pubitemid 38041425)
58. Cosman, F. et al. Resistance to bone resorbing effects of PTH in black women. J. Bone Miner. Res. 12, 958-966 (1997). (Pubitemid 27225007)
59. Stamatelou, K. K. et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 63, 1817-1823 (2003). (Pubitemid 36513328)
60. Gutierrez, O. M. et al. Racial differences in postprandial mineral ion handling in health and in chronic kidney disease. Nephrol. Dial. Transplant. 25, 3970-3977 (2010).
61. Yokoyama, K. et al. Apa I polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease. Kidney Int. 53, 454-458 (1998). (Pubitemid 28097863)
62. Shao, J. S. et al. Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice. J. Biol. Chem. 278, 50195-50202 (2003).
63. Thorleifsson, G. et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat. Genet. 41, 926-930 (2009).
64. Newman, A. B. et al. Racial differences in coronary artery calcification in older adults. Arterioscler. Thromb. Vasc. Biol. 22, 424-430 (2002). (Pubitemid 34218749)
65. Freedman, B. I. et al. The impact of ethnicity and sex on subclinical cardiovascular disease: The Diabetes Heart Study. Diabetologia 48, 2511-2518 (2005). (Pubitemid 41738216)
66. Bild, D. E. et al. Ethnic differences in coronary calcification: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111, 1313-1320 (2005). (Pubitemid 40389097)
67. Carnethon, M. R. et al. Racial/ethnic differences in subclinical atherosclerosis among adults with diabetes: The Multiethnic Study of Atherosclerosis. Diabetes Care 28, 2768-2770 (2005). (Pubitemid 43951173)
68. Budoff, M. J. et al. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis 187, 343-350 (2006). (Pubitemid 43963013)
69. American Diabetes Association. http://www.diabetes.org
70. Young, B. A., Maynard, C. & Boyko, E. J. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 26, 2392-2399 (2003). (Pubitemid 36993332)
71. Karter, A. J. et al. Ethnic disparities in diabetic complications in an insured population. JAMA 287, 2519-2527 (2002). (Pubitemid 34517197)
72. Young, B. A. et al. Racial and ethnic differences in incident myocardial infarction in end-stage renal disease patients: The USRDS. Kidney Int. 69, 1691-1698 (2006).
73. Buckalew, V. M. Jr & Freedman, B. I. Effects of race on albuminuria and risk of cardiovascular and kidney disease. Expert Rev. Cardiovasc. Ther. 9, 245-249 (2011).
74. Collins, A. J. et al. United States Renal Data System. USRDS 2011 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Am. J. Kidney Dis. 59 (Suppl. 1), e1-e420 (2012).
75. Kucirka, L. M. et al. Association of race and age with survival among patients undergoing dialysis. JAMA 306, 620-626 (2011).
76. Buckalew, V. M. & Freedman, B. I. Reappraisal of the impact of race on survival in patients on dialysis. Am. J. Kidney Dis. 55, 1102-1110 (2010).
77. Jain, T. et al. African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study. J. Am. Coll. Cardiol. 44, 1011-1017 (2004). (Pubitemid 39165135)
78. Wagenknecht, L. E. et al. Correlates of coronary artery calcified plaque in blacks and whites with type 2 diabetes. Ann. Epidemiol. 21, 34-41 (2011).
79. Wassel, C. L. et al. Genetic ancestry is associated with subclinical cardiovascular disease in African-Americans and Hispanics from the multi-ethnic study of atherosclerosis. Circ. Cardiovasc. Genet. 2, 629-636 (2009).
80. Divers, J. et al. Ethnic differences in the relationship between pericardial adipose tissue and coronary artery calcified plaque: African American diabetes heart study. J. Clin. Endocrinol. Metab. 95, 5382-5389 (2010).
81. Divers, J. et al. Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: The African American-diabetes heart study. Diabetes Care 33, 131-138 (2010).
82. Wang, T. J. et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 376, 180-188 (2010).
83. Shen, H. et al. Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler. Thromb. Vasc. Biol. 30, 2648-2654 (2010).
84. Freedman, B. I. et al. Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: The Diabetes Heart Study. J. Bone Miner. Res. 24, 1719-1727 (2009).
85. Smith, M. W. et al. A high-density admixture map for disease gene discovery in african americans. Am. J. Hum. Genet. 74, 1001-1013 (2004). (Pubitemid 38568970)
86. Divers, J., Moossavi, S., Langefeld, C. D. & Freedman, B. I. Genetic admixture: A tool to identify diabetic nephropathy genes in African Americans. Ethn. Dis. 18, 384-388 (2008).
87. Kopp, J. B. et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat. Genet. 40, 1175-1184 (2008).
88. Kao, W. H. et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat. Genet. 40, 1185-1192 (2008).
89. Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841-845 (2010).
90. Freedman, B. I. et al. The Apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J. Am. Soc. Nephrol. 21, 1422-1426 (2010).
91. Ferguson, R., Grim, C. E. & Opgenorth, T. J. A familial risk of chronic renal failure among blacks on dialysis? J. Clin. Epidemiol. 41, 1189-1196 (1988). (Pubitemid 19036521)
92. Freedman, B. I., Spray, B. J., Tuttle, A. B. & Buckalew, V. M. Jr. The familial risk of end-stage renal disease in African Americans. Am. J. Kidney Dis. 21, 387-393 (1993). (Pubitemid 23132903)
93. Kopp, J. B. et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 22, 2129-2137 (2011).
94. Razzaque, M. S. The dualistic role of vitamin D in vascular calcifications. Kidney Int. 79, 708-714 (2011).